Psyence Biomedical Ltd. SEC filings PBM
Psyence Biomedical Ltd. has 170 filings in SEC EDGAR's recent list, going back to Aug 1, 2023. Its latest annual report, Form 20-F, was filed on Jun 22, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 6-K | Current report (foreign issuer) | Jun 5, 2026 | Jun 5, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 17, 2026 | Apr 17, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Mar 2, 2026 |
| 6-K | Current report (foreign issuer) | Feb 20, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Feb 13, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 29, 2026 | Jan 29, 2026 |
| 6-K | Current report (foreign issuer) | Jan 27, 2026 | Jan 27, 2026 |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 14, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 6-K/A | Current report | Jan 13, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Nov 21, 2025 | Nov 21, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 6-K | Current report (foreign issuer) | Oct 9, 2025 | Oct 9, 2025 |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 28, 2025 |
| 6-K | Current report (foreign issuer) | Jun 25, 2025 | Jun 25, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | May 20, 2025 | May 20, 2025 |
| 6-K | Current report (foreign issuer) | May 6, 2025 | May 6, 2025 |
| 6-K | Current report (foreign issuer) | Apr 23, 2025 | Apr 23, 2025 |
| 6-K | Current report (foreign issuer) | Apr 11, 2025 | Apr 11, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2025 | Apr 1, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 23, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 31, 2024 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Current report (foreign issuer) | Dec 19, 2024 | Dec 19, 2024 |
| 6-K | Current report (foreign issuer) | Dec 18, 2024 | Dec 18, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 3, 2024 | Dec 3, 2024 |
| 6-K | Current report (foreign issuer) | Nov 22, 2024 | Nov 22, 2024 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 12, 2024 |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Nov 1, 2024 |
| 6-K | Current report (foreign issuer) | Oct 23, 2024 | Oct 23, 2024 |
| 6-K | Current report (foreign issuer) | Oct 8, 2024 | Oct 8, 2024 |
| 6-K | Current report (foreign issuer) | Sep 20, 2024 | Sep 20, 2024 |
| 6-K | Current report (foreign issuer) | Sep 13, 2024 | Sep 13, 2024 |
| 6-K | Current report (foreign issuer) | Sep 5, 2024 | Sep 5, 2024 |
| 6-K | Current report (foreign issuer) | Aug 30, 2024 | Aug 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 20, 2024 | Aug 20, 2024 |
| 6-K | Current report (foreign issuer) | Jul 31, 2024 | Jul 31, 2024 |
| 6-K | Current report (foreign issuer) | Jul 24, 2024 | Jul 24, 2024 |
| 6-K | Current report (foreign issuer) | Jul 23, 2024 | Jul 23, 2024 |
| 6-K | Current report (foreign issuer) | Jul 5, 2024 | Jul 5, 2024 |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 12, 2024 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBM (Nasdaq), PBMWW (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1985062
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.